Edition:
United Kingdom

Healthcare Headlines

Cholesterol drug maker pays $4.1 mln to settle fraud charges-SEC

Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, will pay $4.1 million to settle charges it misled investors about how many patients purchased Juxtapid, a drug used to treat a genetic condition that leads to high cholesterol, the top U.S. securities regulator said on Friday.

U.S. oil drillers cut rigs for 3rd week in a row -Baker Hughes

U.S. energy firms cut the number of oil rigs operating for a third week in a row as a 14-month drilling recovery stalled as companies pared back on spending plans when crude prices were softer. Drillers cut five oil rigs in the week to Sept. 22, bringing the total count down to 744, the least since June, General Electric Co's Baker Hughes energy services firm said in its closely followed report on Friday. That put the rig count on tra